Advanced Search
Share
Current Issue
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
Guilherme Rasia Bosi
Corresponding author
guibosi@hotmail.com

Corresponding author at: Serviço de Hematologia e Transplante de Medula Óssea do Hospital de Clínicas de Porto Alegre, R. Ramiro Barcelos, 2350 – Santa Cecilia, Porto Alegre CEP: 90035-007, RS, Brazil.
, Laura Maria Fogliatto, Tito Emilio Vanelli Costa, Kamila Castro Grokoski, Mariana Pinto Pereira, Nathan Bugs, Marco Kalil, Christina Fraga, Liane Esteves Daudt, Lucia Mariano da Rocha Silla
Universidade Federal do Rio Grande do Sul (UFRS), Porto Alegre, RS, Brazil
Read
3676
Times
was read the article
1408
Total PDF
2268
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
DOI:10.1016/j.htct.2018.11.005
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 17 10 27
2024 March 57 22 79
2024 February 49 26 75
2024 January 48 25 73
2023 December 37 21 58
2023 November 58 28 86
2023 October 58 35 93
2023 September 66 39 105
2023 August 45 9 54
2023 July 52 17 69
2023 June 78 30 108
2023 May 50 24 74
2023 April 37 24 61
2023 March 46 21 67
2023 February 31 16 47
2023 January 30 7 37
2022 December 44 20 64
2022 November 46 25 71
2022 October 49 23 72
2022 September 40 42 82
2022 August 36 22 58
2022 July 44 21 65
2022 June 34 28 62
2022 May 25 23 48
2022 April 58 25 83
2022 March 33 22 55
2022 February 29 32 61
2022 January 29 25 54
2021 December 30 23 53
2021 November 31 30 61
2021 October 60 44 104
2021 September 37 34 71
2021 August 31 28 59
2021 July 30 21 51
2021 June 21 33 54
2021 May 36 31 67
2021 April 74 61 135
2021 March 35 28 63
2021 February 29 18 47
2021 January 22 19 41
2020 December 22 14 36
2020 November 22 20 42
2020 October 10 9 19
2020 September 21 19 40
2020 August 30 16 46
2020 July 13 7 20
2020 June 26 19 45
2020 May 40 13 53
2020 April 16 9 25
2020 March 18 12 30
2020 February 30 22 52
2020 January 23 19 42
2019 December 20 16 36
2019 November 28 20 48
2019 October 43 17 60
2019 September 76 19 95
2019 August 26 12 38
2019 July 34 18 52
2019 June 30 14 44
2019 May 30 29 59
2019 April 43 33 76
2019 March 5 19 24
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy